Molecular characterisation of a coxsackievirus A24 that caused an outbreak of acute haemorrhagic conjunctivitis, Tunisia 2003  by Triki, H. et al.
ORIGINAL ARTICLE 10.1111/j.1469-0691.2006.01618.x
Molecular characterisation of a coxsackievirus A24 that caused an outbreak
of acute haemorrhagic conjunctivitis, Tunisia 2003
H. Triki1, D. Rezig1, O. Bahri1, N. Ben Ayed2, A. Ben Yahia1, A. Sadraoui1 and S. Ayed2
1Laboratory of Clinical Virology, WHO Regional Reference Laboratory on Poliomyelitis and Measles,
Institut Pasteur de Tunis and 2Institute of Ophthalmology Hedi Rais, Tunisia
ABSTRACT
This study reports the genetic characteristics of coxsackievirus A24 isolates from Tunisia, including a
coxsackievirus A24 variant (CVA24v) that caused an outbreak of acute haemorrhagic conjunctivitis
(AHC) between September and November 2003. The virus genome was detected by PCR from
conjunctival swabs obtained from patients with AHC. Four virus isolates were obtained from PCR-
positive samples and were serotyped by sequence analysis of the VP1 and VP4 genomic region and by
seroneutralisation. Phylogenetic analysis of the VP1, VP4 and 3C genomic regions was performed. Other
Tunisian CVA24 isolates from paralytic cases and healthy individuals were also ampliﬁed, sequenced
and included in the phylogenetic analysis. The epidemic strain belonged to the CVA24 serotype.
Phylogenetic analysis of the 3C region of the genome revealed a strong relationship between the
Tunisian epidemic strain and strains that caused outbreaks in Korea (2002) and Guadeloupe and French
Guiana (2003). Phylogenetic analysis of the VP1 and VP4 regions showed a clear distinction between
serotype CVA24 isolates from conjunctivitis and non-conjunctivitis cases. This is the ﬁrst study to report
an outbreak of AHC caused by CVA24v in the North African region.
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INTRODUCTION
Acute haemorrhagic conjunctivitis (AHC) is a
highly contagious epidemic eye disease, caused
most commonly by two enterovirus serotypes,
enterovirus 70 (EV70) and coxsackievirus A24
variant (CVA24v), and less frequently by some
adenovirus serotypes [1]. CVA24v is distinct
antigenically from the Joseph prototype strain
and other CVA24 strains, and was ﬁrst isolated
from an outbreak of AHC in Singapore during
1970 [2]. CVA24v caused large outbreaks of AHC
in India and southeast Asia until the mid-1980s,
and then spread rapidly to other regions of the
world [3–7]. In addition to AHC, isolates belong-
ing to the CVA24 serotype have been isolated
from healthy individuals and patients with the
common cold, diarrhoea and acute ﬂaccid para-
lysis, but CVA24 is not generally among the most
commonly isolated enterovirus serotypes [8–11].
During autumn 2003, an outbreak of AHC
occurred in Tunisia, with cases in most govern-
orates of the country. Records from the National
Ophthalmology Institute, a large clinic in Tunis,
indicated that the outbreak started in early Sep-
tember, peaked during the ﬁrst week of October,
and ended by the beginning of November, lasting
for a total of c. 9 weeks. During this period, 3944
cases were seen in the emergency department of
the Ophthalmology Institute alone. Conjunctival
swabs were taken from patients and forwarded to
the virology laboratory at the Pasteur Institute of
Tunis for analysis. The present article describes
the virological and phylogenetic analysis of this
outbreak.
MATERIALS AND METHODS
Clinical samples from AHC cases
Between 13 September and 27 October 2003, 77 conjunctival
swabs were received from the National Institute of Ophthal-
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mology for analysis. Sterile cotton swabs were used to sample
tears and eye discharges. The swabs were then immediately
placed in 2 mL of virological transport medium (1· Eagle’s
MinimumMedium containing 2% v ⁄v of an antibiotic solution
containing penicillin 2 U ⁄mL and gentamicin 0.5 mg ⁄mL).
After collection, the samples were transported on ice to the
virology laboratory at the Pasteur Institute of Tunis.
Virus detection and isolation
The samples were ﬁrst screened by PCR for enterovirus and
adenovirus. The enterovirus PCR used three enterovirus-speci-
ﬁc primers described previously [12]: EV-RT (reverse), nucleo-
tides 717–728, 5¢-CACTCGGATGGCC; EV-NC2 (reverse),
nucleotides 667–687, 5¢-ATTGTCACCATAAGCAGCCA; and
EV-NC1 (forward), nucleotides 358–374, 5¢-GCGTTGCGCT
CAGCAC. Virus RNA was extracted from 100 lL of clinical
sample usingTRIzol (InvitrogenLife Technologies, Paisley,UK)
and chloroform, precipitated, dried, and redissolved in sterile
water. Reverse transcription was performed in a reaction
mixture containing the extracted virus RNA, 10 lM reverse
EV-RT primer, 35 U of RNAguard (Promega, Madison, WI,
USA), 10 mM dNTP mix (Amersham Pharmacia Biotech,
Piscataway, NJ, USA), 5 U of avian myeloblastosis reverse
transcriptase (Boehringer, Mannheim, Germany) and 2 lL of 5·
enzyme buffer, in a total volume of 10 lL. The mixture was
incubated at 42C for 45 min. The total volume of cDNA was
then used for PCR in the presence of 10 lM EV-NC2 primer,
10 lM EV-NC1 primer, 2 lL of formamide (Sigma Chemical
Co., St Louis, MO, USA), 20 mM dNTPs, 2.5 U of Taq poly-
merase (Amersham Pharmacia Biotech) and 3 lL of 10· Taq
buffer (Amersham Pharmacia Biotech). Distilled water was
added to a ﬁnal volume of 50 lL. PCR comprised 40 cycles of
15 s at 94C, 15 s at 60C and 15 s at 72C, followed by a ﬁnal
elongation step of 5 min at 72C. Ampliﬁcation products were
visualised by agarose gel electrophoresis and ethidiumbromide
staining.
The adenovirus PCR involved ampliﬁcation of a 161-bp
region of the adenovirus hexon gene with primer Ad2
(reverse), nucleotides 2888–2866, 5¢-GCCGAGAAGGGCGT-
GCGCAGGTA, and primer Ad1 (forward), nucleotides
2728–2750, 5¢-TACGCCAACTCCGCCCACGCGCT [13]. Virus
DNA was extracted by mixing 100 lL of clinical sample with
40 lL of proteinase K (100 lg ⁄mL) and 360 lL of lysis buffer
(50 mM Tris, pH 7.5, 1 M b-mercaptoethanol, guanidium
thiocyanate and glycogen) in a 1.5-mL Eppendorf tube. The
mixture was incubated for 1 h at 58C and then extracted once
with phenol–chloroform–isoamyl alcohol (25:24:1) and twice
with chloroform–isoamyl alcohol (24:1). For PCR ampliﬁca-
tion, the reaction mixture comprised 20 mM each dNTP,
10 lMAd1 primer, 10 lMAd2 primer, 75 mMMgCl2, 2.5 U of
Taq polymerase, 3 lL of 10· Taq buffer, and distilled water to a
ﬁnal volume of 50 lL. The PCR comprised 30 cycles of 30 s at
94C, 30 s at 61C and 30 s at 72C, followed by a ﬁnal
elongation step of 10 min at 72C.
Virus isolation from cell culture was performed with PCR-
positive samples. RD (rhabdomyosarcoma) and HEp2-c (hu-
man epidermoid carcinoma of the larynx) cell lines were
inoculated with 200 lL of clinical samples. When a complete
cytopathic effect (CPE) was obtained, the infected cells were
harvested and kept frozen at )20C until typing. Cell cultures
were followed for a minimum of 14 days in the absence of any
CPE.
PCR ampliﬁcation and partial sequencing of the VP1, VP4
and 3C regions of the enterovirus genome
A 356-base fragment of the 5¢-half of the VP1-coding region of
the genome (nucleotides 2613–2969) was ampliﬁed by PCR as
described previously [14]. In the VP4 region, a c. 650-base
ampliﬁcation product was obtained with primers MD91
(forward), nucleotides 444–468, 5¢-CCTCCGGCCCCTGAA-
TGCGGCTAAT, and OL68-1 (reverse), nucleotides 1178–
1197, 5¢-GGTAA(C ⁄T)TTCCACCACCA(A ⁄T ⁄G ⁄C)CC [15].
A 674-base ampliﬁcation product from the 3C region was
obtained using primers D1 (forward), nucleotides 5371–5380,
5¢-TACAAACTGTTTGCTGGGCA, and U2 (reverse), nucleo-
tides 6025–6044, 5¢-ACTTCTTTTGATGGTCTCAT [16]. The
ampliﬁcation products were puriﬁed using a QiaQuick gel
extraction kit (Qiagen, Hilden, Germany). Sequencing was
performed with a Taq Dye Deoxyterminator Cycle Sequen-
cing Kit and an ABI PRISM 377-3.0 automated sequencer
(Applied Biosystems, Darmstadt, Germany), using the
same forward and reverse primers that were used for PCR
ampliﬁcation.
Serological and molecular typing
Ampliﬁed sequences of the VP1 region were compared with
sequences from human enteroviruses (GenBank database,
FASTA program) [17]. The CVA24 serotype was assigned to
the isolates according to the criteria for molecular typing
proposed previously [18], i.e., ‡75% identity with the CVA24
prototype strains and <70% identity with the prototype strains
of the serotype having the second-highest identity score. The
CVA24 serotype was further conﬁrmed by seroneutralisation
of the CPE using H-R pools from RIVM (Bilthoven, The
Netherlands).
Other virus isolates belonging to serotype CVA24
Eight other virus strains belonging to the CVA24 serotype,
isolated in Tunisia and Morocco in 1994–2000, were also
analysed. These strains were obtained through the poliomy-
elitis surveillance programme, and came from acute ﬂaccid
cases of paralysis (n = 3) or from healthy individuals (n = 5)
after inoculation of stool samples on HEp2-c and RD cell lines
according to the standard protocols recommended by the
WHO [19]. Initial attempts were made to identify the serotype
by seroneutralisation of the CPE using the enterovirus pools of
antiserum provided through the WHO poliovirus surveillance
programme. These pools allow identiﬁcation of the 27 most
common enterovirus serotypes. However, none of the isolates
was neutralised by these pools, which do not contain CVA24-
speciﬁc antisera (personal unpublished results). Before
molecular analysis, high-titre virus stocks were prepared by
re-infection of HEp2-c or RD cells with the original isolate. The
serotype was then investigated by partial sequencing of the
VP1 genomic region, as described above, followed by sero-
neutralisation with the RIVM H-R pools to conﬁrm the
serotype.
Phylogenetic analysis
The sequences obtained were compared with each other and
with the sequences from the same genomic region available in
GenBank. In total, 120 sequences in the 3C, VP1 or VP4
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genomic regions of CVA24 isolates and prototype strains of
other serotypes were used, as listed in Table S1 (see Supple-
mentary material). Sequence relationship was assessed using
the ClustalX program for multiple alignments [20] with default
parameters. Genetic distances were calculated using the
Kimura-2 parameter, with a transition ⁄ transversion ratio (k)
of 8.0 [21]. Phylogenetic trees were generated from the aligned
sequences using the PHYLIP (Phylogeny Inference Package)
v.3.5 with DNADIST [22]. Phylogenetic trees were constructed
using the neighbour-joining algorithm in the PHYLIP program
[23]. Bootstrapping of 1000 replicas was performed. Bootstrap
values ‡70% were considered to be statistically signiﬁcant for
grouping purposes [24]. The phylogenetic trees were drawn
using the TREEVIEW program [25]. The sequences from this
study were submitted to GenBank under accession numbers
AJ715967–AJ715978.
RESULTS
Virus detection in clinical samples
Of 77 eye swabs received, 50 were subjected to
PCR analysis for detection of enterovirus and
adenovirus, based on ﬁve samples per week and
per geographical region. PCR assays were posit-
ive for enterovirus with 31 samples, and for
adenovirus with two samples. Virus isolates were
grown in cell cultures from ten samples that were
PCR-positive for enterovirus, all of which
were from Tunis. Of these, four were selected
for serotype identiﬁcation and genetic character-
isation by sequencing partial VP1, VP4 and 3C
genomic regions (Table 1). These four samples
included isolates from the beginning, the middle
and the end of the outbreak.
Serotype identiﬁcation
The four selected isolates from eye swabs were
sequenced in both directions in the 5¢-half of the
VP1 region. The sequences obtained had 85.3%
identity with the EH24Singapore1970 prototype
CVA24v strain. The serotype with the second
highest identity score was coxsackievirus A11
(prototype strain Belgium-1), with 73.8% nuc-
leotide identity. It was concluded that enterovi-
rus serotype CVA24v was the probable
causative agent of the outbreak. The isolates
were also ampliﬁed and sequenced in the VP4
region, and the sequences obtained again had
the highest identity score (82.4%) with the
EH24Singapore1970 prototype CVA24v strain.
The serotype with the second-highest identity
was coxsackievirus A11 (prototype strain Bel-
gium-1) with 78.2% nucleotide identity. The K
and R pools from RIVM were able to seroneu-
tralise the CPE, thus conﬁrming the CVA24
serotype.
Sequence analysis in the 3C genomic region
A 674-base fragment comprising the 3C genomic
region of the Tunisian epidemic isolate was
ampliﬁed and sequenced. A 549-base fragment
of the 3C region (nucleotides 5461–6009) was then
compared with GenBank sequences of other
CVA24v strains that had caused epidemics of
AHC (Fig. S1; see Supplementary material). The
epidemic strain Tunisia 2003 clustered with the
epidemic strains involved in the outbreaks of
AHC in Korea (2002) and in Guadeloupe and
French Guiana (2003), with very high nucleotide
identities of 96.8–97.5% within this cluster
(Fig. S1; cluster 6). The other epidemic strains,
mostly from Asia (China, Hong Kong, Pakistan,
Singapore, Japan and Taiwan), segregated into
ﬁve other clusters. Clusters 1 and 2 comprised
isolates from the 1970s, and clusters 3, 4 and 5
comprised isolates from the 1980s. Cluster 3
contained isolates from 1985–1986, cluster 4 con-
tained mostly isolates from 1987 and 1988, and
cluster 5 included isolates from 1989, with a few
isolates from 1988.
Table 1. CVA24 isolates from Tuni-
sia used for genetic characterisation
in this study
Isolate ⁄xname
Database
accession no.
Geographical
origin
Year of
isolation
Sample
origin Pathology
A19Tunisia2003 AJ715967 Tunisia 2003 Eye swabs Conjunctivitis
A22Tunisia2003 AJ715968 Tunisia 2003 Eye swabs Conjunctivitis
A26Tunisia2003 AJ715969 Tunisia 2003 Eye swabs Conjunctivitis
A31Tunisia2003 AJ715970 Tunisia 2003 Eye swabs Conjunctivitis
S4Tunisia2000 AJ715971 Tunisia 2000 Stools AFP
S65Tunisia1994 AJ715972 Tunisia 1994 Stools AFP
S161Morocco1999 – Morocco 1999 Stools AFP
Tt116Tunisia1995 AJ715973 Tunisia 1995 Stools Healthy individual
Nb69Tunisia1995 AJ715974 Tunisia 1995 Stools Healthy individual
Md136Tunisia1995 AJ715975 Tunisia 1995 Stools Healthy individual
Ks14Tunisia1994 AJ715977 Tunisia 1994 Stools Healthy individual
Ks17Tunisia1994 AJ715978 Tunisia 1994 Stools Healthy individual
AFP, acute ﬂaccid paralysis.
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Phylogenetic analysis of the VP1 and VP4
genomic regions
Sequences of the VP1 and VP4 genomic regions
were compared with other GenBank sequences of
the same regions. The phylogenetic dendrograms
obtained are shown in Figs S2 and S3 (see
Supplementary material). In contrast to the 3C
genomic region, GenBank does not contain many
VP1 and VP4 genomic sequences from AHC
outbreaks. However, some sequences were avail-
able from patients with clinical symptoms other
than AHC. The dendrograms shown in Figs S2
and S3 also include the partial VP1 and VP4
sequences that were obtained for eight CVA24
isolates from cases of paralysis and healthy indi-
viduals in Tunisia (n = 7) and Morocco (n = 1).
In the VP1 tree, all CVA24 isolates grouped
together with the two prototype strains of
the CVA24 serotype (EH24Singapore1970 and
JosephSouthAfrica1952), and separately from the
prototype strains of the other serotypes. This
conﬁrms the correlation between sequence iden-
tity and serotype in this genomic region described
previously. In contrast, the VP4 tree showed no
correlation with serotype; the different isolates
from the CVA24 serotype did not group together
and were distributed throughout the tree with
prototype sequences of other serotypes. In both
trees, all sequences from AHC cases ⁄ outbreaks
grouped together, separate from other CVA24
isolates.
In the VP1 region, with the exception of the
EH24 Singapore1970 prototype strain, the only
sequences contained in GenBank are those of the
recent outbreaks in Korea (2002) and Guadeloupe–
French Guiana (2003), as well as a French isolate
from a sporadic case of AHC. The Tunisian
epidemic CVA24v strain had the highest identity
with the epidemic strains from Korea and Guade-
loupe (99.6% with each). In the VP4 region, the
sequences of the recent outbreaks have not been
reported, so that the only sequences from AHC
outbreaks available in GenBank are those from
isolates in the 1970s and the 1980s. As was found
with the 3C region, different temporal clusters
were revealed. One cluster included isolates
from the early 1970s, a second included isolates
from the mid-1970s, a third included isolates from
1985—1987, and a fourth included isolates from
1988—1989. The Tunisian strain clustered with the
most recent isolate from Japan (1989), with 91.7%
nucleotide identity. For the CVA24 strains isolated
from non-conjunctivitis cases, both the VP1 and
VP4 trees showed that the Tunisian sequences
from healthy individuals (Ks14Tunisia1994,
Ks17Tunisia1994, Md136Tunisia1995, Nb69Tuni-
sia1995 and Tt116Tunisia1995) grouped separately
to the sequences from paralytic cases (S65Tuni-
sia1994, S161Morocco1999 and S4Tunisia2000).
Sequences from cases of AHC were relatively
close to each other, with nucleotide identities of
91.2–100% in VP1 and 80.0–99.5% in VP4,
whereas sequences from non-conjunctivitis cases
were heterogeneous and more divergent, with
nucleotide identities of 72.7–100% in VP1 and
69.5–92.9% in VP4.
DISCUSSION
Outbreaks of AHC have occurred previously in
Tunisia, generally starting in late summer and
lasting until autumn. This period of the year is
characterised by high temperatures and frequent
rainfall, which are two climatic factors that are
generally associated with the high transmission
period of some viruses, including enteroviruses.
The causative agents of these outbreaks were
determined only rarely at the time of the out-
break, except during summer–autumn 2000,
when several adenovirus isolates were obtained
from the patients affected (personal unpublished
data). The present study demonstrated that the
AHC outbreak in Tunisia during 2003 was caused
by CVA24v, although two patients yielded iso-
lates of adenovirus. To our knowledge, this is the
ﬁrst time that the CVA24v serotype has been
reported in north Africa. Until 1985, AHC caused
by CVA24v was conﬁned to south-east Asia and
India, where repeated epidemics occurred
[16,26,27]. The virus then spread, causing large
outbreaks in Taiwan, Japan and some countries in
central America, with a few reports from Euro-
pean and African countries [3–7,28–31]. During
2002–2003, three outbreaks caused by CVA24v
were reported in South Korea (2002), Malaysia
(2003) and the French West Indies, Martinique
and Guadeloupe (2003) [32–34]. Concomitantly
with the Tunisian epidemic, an outbreak of AHC
in Algeria was reported that affected at least
40 000 individuals (http://www.promedmail
org ⁄ archive no. 200308292177). The identity of
the infectious agent in Algeria has not yet been
reported, but it is likely that the Tunisian and
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Algerian outbreaks were caused by the same
virus. The Tunisian isolate showed very high
nucleotide identity with the isolates from Korea,
French Guiana and Guadeloupe. This suggestion
that the same virus may have spread and caused
outbreaks is feasible, given the highly contagious
nature of CVA24v, the great mobility of human
populations across the world, and the impressive
speed of modern transport. It is likely that the
Malaysian epidemic strain is also closely related,
but the detailed sequence data are not available in
GenBank, so the Malaysian strain could not be
included in the present phylogenetic analysis.
Most studies of AHC outbreaks caused by
CVA24v have used the 3C genomic region for
molecular epidemiological analysis. Three geno-
types of CVA24 variants, designated I–III, have
been identiﬁed previously. Genotype I corres-
ponds to isolates from the early 1970s, genotype II
to isolates from the mid-1970s, and genotype III to
isolates from the 1980s and the 1990s [35]. Several
clusters have been identiﬁed within genotype III,
with each cluster corresponding to an outbreak
affecting a limited number of neighbouring coun-
tries. Subsequent studies of the outbreaks during
2002–2003 in Korea, Guadeloupe and French
Guiana showed that these epidemic strains were
related to each other and formed a new cluster
[32,34]. The Tunisian epidemic strain also be-
longed to this new cluster, thereby further high-
lighting the extent of the 2002–2003 epidemic,
which affected countries in at least three conti-
nents.
The present study sequenced and analysed the
partial VP1 and VP4 regions of the Tunisian
CAV24 isolates. It has been suggested that the
VP1 and VP4 regions of the enterovirus genome
are suitable for serotyping, thus providing an
important new analytical tool that avoids time-
consuming classical serotyping by seroneutralisa-
tion, and the problems related to the availability
of enterovirus-speciﬁc antisera [14,15,36]. The
present study conﬁrmed these ﬁndings for the
VP1 region, but not for the VP4 region, in that
the sequences of all the CVA24 isolates did not
group together with the prototype CVA24 strains,
and separately from the other prototypes (Fig. S3),
thereby suggesting that the VP4 genomic region is
less suitable for serotype identiﬁcation than the
VP1 region.
Several studies have also demonstrated that the
capsid region may be used for molecular epide-
miological studies. The capsid region may be
even more informative than the 3C region because
of the possibility of recombination between en-
teroviruses and serological pressure on the capsid
region. The capsid region may therefore evolve
faster than the region encoding non-structural
proteins. Although there are few sequences avail-
able from AHC outbreaks for these two genomic
regions, the results were comparable with those
obtained for the 3C region. For the VP1 region, all
epidemic strains, including the Tunisian strain,
formed a single cluster, with 99.3–99.6% identity
between the sequences. For the VP4 region,
different temporal clusters were found (see
Results), and the Tunisian strain clustered with
the most recent isolates from 1988 and 1989.
Phylogenetic analysis, based on sequences from
the capsid region, offers the advantage of using
the same sequence data generated for serotype
identiﬁcation, without further ampliﬁcation of
other genomic regions. As more VP1 and ⁄ or
VP4 regions are sequenced for serotyping and
other purposes, it should be possible to obtain a
better baseline for molecular epidemiological
studies of enteroviruses.
Interestingly, both the VP1 and VP4 trees
showed that isolates from non-conjunctivitis cases
grouped together, separate to those from cases of
AHC, which formed a separate cluster that
included the EH24Singapore1970 prototype
strain. Outside this cluster, Tunisian sequences
from healthy individuals also grouped separately
to sequences from cases of paralysis. For most
enterovirus serotypes, a clear correlation between
genetic variability and pathogenic phenotype has
yet to be established. Several enterovirus sero-
types, and different genotypes within the same
serotype, can induce the same clinical disease.
Thus, many echoviruses and coxsackieviruses can
cause viral meningitis. The three different sero-
types of polioviruses, as well as the numerous
genotypes within each serotype, can all cause the
same paralytic disease. The same virus strain may
induce either a clinical disease or an asympto-
matic infection. Most enteroviruses are character-
ised by a signiﬁcant amount of ‘silent’ circulation
in the human population.
The present results conﬁrm that virus strains
isolated from cases of conjunctivitis belong to an
antigenic variant that is speciﬁc to this pathology,
and that they are genetically different
from CVA24 isolates involved in other clinical
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presentations. However, whether CVA24v iso-
lates speciﬁc to conjunctivitis can also induce
asymptomatic infection remains unclear, as most
studies have only characterised virus strains
isolated from cases of conjunctivitis. Data con-
cerning enterovirus circulation in Tunisia indicate
that c. 30 different enterovirus serotypes have
circulated in Tunisia during the last decade [18].
Other than isolates obtained from suspected cases
of polio and meningitis, most isolates were from
healthy individuals, and no isolate related to
CVA24v was detected. These results support the
hypothesis that CVA24v is associated systematic-
ally with symptomatic AHC. As for other CVA24
strains, the ﬁnding that isolates from asympto-
matic infection cluster separately to isolates from
cases of paralysis should be conﬁrmed by further
studies with larger numbers of isolates.
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SUPPLEMENTARY MATERIAL
The following supplementary material is avail-
able for this article online at http://blackwell-
synergy.com:
Table S1. List of sequences from GenBank used
in the phylogenetic comparisons.
Fig. S1. Dendogram showing phylogenetic rela-
tionships among the Tunisian epidemic strain and
85 CVA24 variant strains responsible for out-
breaks of acute haemorrhagic conjunctivitis
worldwide.
Fig. S2. Dendogram showing phylogenetic rela-
tionships among 60 CVA24 strains, based on an
analysis of the 5´-half of the VP1 coding region
(356 nucleotides).
Fig. S3. Dendogram showing phylogenetic rela-
tionships among 60 CVA24 strains, based on an
analysis of the VP4 genomic region (207 nucleo-
tides).
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